Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (Drugs & Aging, (2015), 32, 3, (179-187), 10.1007/s40266-015-0243-3);Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

Drugs and Aging

Volumn 32, Issue 3, 2015, Pages 179-187

  Bruyère, Olivier ^a   Cooper, Cyrus ^b,c   Arden, Nigel ^b,c   Branco, Jaime ^d   Brandi, Maria Luisa ^e   Herrero Beaumont, Gabriel ^f   Berenbaum, Francis ^g   Dennison, Elaine ^b   Devogelaer, Jean Pierre ^h   Hochberg, Marc ⁱ   Kanis, John ^j   Laslop, Andrea ^k   McAlindon, Tim ^l   Reiter, Susanne ^m   Richette, Pascal ⁿ   Rizzoli, René ^o   Reginster, Jean Yves ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^g HÔPITAL SAINT ANTOINE   (France)

^h CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

ⁱ UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF SHEFFIELD   (United Kingdom)

^k AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^l TUFTS MEDICAL CENTER   (United States)

^m Federal Institute for Drugs and Medical Devices Bundesinstitut für Arzneimittel und Medizinprodukte   (Germany)

ⁿ UNIVERSITÉ PARIS DESCARTES   (France)

^o GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE DENSITY; CLINICAL EVALUATION; DISEASE COURSE; GENETICS; HIGH RISK PATIENT; HUMAN; INFORMATION RETRIEVAL; JOINT INJURY; KNEE OSTEOARTHRITIS; MUSCLE WEAKNESS; OBESITY; OSTEOARTHRITIS; PREVALENCE; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; RISK FACTOR; TREATMENT RESPONSE; BONE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE;

BONE AND BONES; BONE DENSITY; DISEASE PROGRESSION; HUMANS; OSTEOARTHRITIS; PHENOTYPE; RISK FACTORS;

EID: 84925487370     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-017-0456-8     Document Type: Erratum

References (82)

1. Roman-Blas JA, Castaneda S, Largo R, et al. Osteoarthritis associated with estrogen deficiency. Arthritis Res Ther. 2009;11:241.
2. Herrero-Beaumont G, Roman-Blas JA, Castaneda S, et al. Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics. Semin Arthritis Rheum. 2009;39:71–80.
3. Cooper C, Adachi JD, Bardin T, et al. How to define responders in osteoarthritis. Curr Med Res Opin. 2013;29:719–29.
4. Pelletier JP, Cooper C, Peterfy C, et al. What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? Ann Rheum Dis. 2013;72:1594–604.
5. Lotz M, Martel-Pelletier J, Christiansen C, et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis. 2013;72:1756–63.
6. Karsdal MA, Christiansen C, Ladel C, et al. Osteoarthritis–a case for personalized health care? Osteoarthritis Cartilage. 2014;22:7–16.
7. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377:2115–26.
8. Castaneda S, Roman-Blas JA, Largo R, et al. Osteoarthritis: a progressive disease with changing phenotypes. Rheumatology (Oxford). 2014;53:1–3.
9. Kinds MB, Marijnissen AC, Bijlsma JW, et al. Quantitative radiographic features of early knee osteoarthritis: development over 5 years and relationship with symptoms in the CHECK cohort. J Rheumatol. 2013;40:58–65.
10. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.
11. Kellgren JH, Lawrence JS. The epidemiology of chronic rheumatism: atlas of standard radiographs. 2nd ed. Oxford: Blackwell Scientific; 1963.
12. Cooper C, McAlindon T, Snow S, et al. Mechanical and constitutional risk factors for symptomatic knee osteoarthritis: differences between medial tibiofemoral and patellofemoral disease. J Rheumatol. 1994;21:307–13.
13. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039–49.
14. Prieto-Alhambra D, Judge A, Javaid MK, et al. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis. 2014;73:1659–64.
15. Oliveria SA, Felson DT, Reed JI, et al. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 1995;38:1134–41.
16. van Saase JL, van Romunde LK, Cats A, et al. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis. 1989;48:271–80.
17. Culliford DJ, Maskell J, Beard DJ, et al. Temporal trends in hip and knee replacement in the United Kingdom: 1991–2006. J Bone Joint Surg Br. 2010;92:130–5.
18. Cooper C, Arden NK. Excess mortality in osteoarthritis. BMJ. 2011;342:d1407.
19. Nuesch E, Dieppe P, Reichenbach S, et al. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ. 2011;342:d1165.
20. Lohmander LS, Felson D. Can we identify a ‘high risk’ patient profile to determine who will experience rapid progression of osteoarthritis? Osteoarthritis Cartilage. 2004;12(Suppl A):S49–S52.
21. Bruyère O, Cooper C, Pavelka K, et al. Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years. Calcif Tissue Int. 2013;93:502–7.
22. Bruyère O, Richy F, Reginster JY. Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up study. Ann Rheum Dis. 2005;64:1727–30.
23. Soni A, Kiran A, Hart DJ, et al. Prevalence of reported knee pain over twelve years in a community-based cohort. Arthritis Rheum. 2012;64:1145–52.
24. Leyland KM, Hart D, Javaid MK, et al. The natural history of radiographic knee osteoarthritis: a 14 year population-based study. Arthritis Rheum. 2012;64:2243–51.
25. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145–55.
26. Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:377–88.
27. Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005;64:669–81.
28. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64:465–74.
29. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16:137–62.
30. National Institute for Health and Clinical Excellence. Osteoarthritis: care and management in adults. 2014. http://www.nice.org.uk/guidance/cg177. Accessed 17 Dec 2014.
31. Conaghan PG, Dickson J, Grant RL. Care and management of osteoarthritis in adults: summary of NICE guidance. BMJ. 2008;336:502–3.
32. European Medicines Agency. Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis. 2010. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003440.pdf. Accessed 25 May 2013.
33. Bauer DC, Hunter DJ, Abramson SB, et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage. 2006;14:723–7.
34. Kraus VB, Burnett B, Coindreau J, et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage. 2011;19:515–42.
35. Conaghan PG, Hunter DJ, Maillefert JF, et al. Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. Osteoarthritis Cartilage. 2011;19:606–10.
36. Eckstein F, Kwoh CK, Boudreau RM, et al. Quantitative MRI measures of cartilage predict knee replacement: a case-control study from the Osteoarthritis Initiative. Ann Rheum Dis. 2013;72:707–14.
37. Bowers ME, Tung GA, Fleming BC, et al. Quantification of meniscal volume by segmentation of 3T magnetic resonance images. J Biomech. 2007;40:2811–5.
38. Roemer FW, Guermazi A, Felson DT, et al. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis. 2011;70:1804–9.
39. Guermazi A, Roemer FW, Hayashi D. Imaging of osteoarthritis: update from a radiological perspective. Curr Opin Rheumatol. 2011;23:484–91.
40. Nelson AE, Smith MW, Golightly YM, et al. “Generalized osteoarthritis”: a systematic review. Semin Arthritis Rheum. 2014;43:713–20.
41. Cattano NM, Driban JB, Balasubramanian E, et al. Biochemical comparison of osteoarthritic knees with and without effusion. BMC Musculoskelet Disord. 2011;12:273.
42. Driban JB, Balasubramanian E, Amin M, et al. The potential of multiple synovial-fluid protein-concentration analyses in the assessment of knee osteoarthritis. J Sport Rehabil. 2010;19:411–21.
43. Kraus VB, Jordan JM, Doherty M, et al. The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage. 2007;15:120–7.
44. Kerkhof HJ, Bierma-Zeinstra SM, Castano-Betancourt MC, et al. Serum C reactive protein levels and genetic variation in the CRP gene are not associated with the prevalence, incidence or progression of osteoarthritis independent of body mass index. Ann Rheum Dis. 2010;69:1976–82.
45. Vlad SC, Neogi T, Aliabadi P, et al. No association between markers of inflammation and osteoarthritis of the hands and knees. J Rheumatol. 2011;38:1665–70.
46. Siebuhr AS, Petersen KK, Arendt-Nielsen L, et al. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover. Osteoarthritis Cartilage. 2014;22:44–50.
47. van Spil WE, Nair SC, Kinds MB, et al. Systemic biochemical markers of joint metabolism and inflammation in relation to radiographic parameters and pain of the knee: data from CHECK, a cohort of early-osteoarthritis subjects. Osteoarthritis Cartilage. 2015;23:48–56.
48. Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis. 2013;5:77–94.
49. Mazzuca SA, Brandt KD, Chakr R, et al. Varus malalignment negates the structure-modifying benefits of doxycycline in obese women with knee osteoarthritis. Osteoarthritis Cartilage. 2010;18:1008–11.
50. Gudbergsen H, Boesen M, Christensen R, et al. Radiographs and low field MRI (0.2T) as predictors of efficacy in a weight loss trial in obese women with knee osteoarthritis. BMC Musculoskelet Disord. 2011;12:56.
51. Gudbergsen H, Boesen M, Lohmander LS, et al. Weight loss is effective for symptomatic relief in obese subjects with knee osteoarthritis independently of joint damage severity assessed by high-field MRI and radiography. Osteoarthritis Cartilage. 2012;20:495–502.
52. Hellio Le Graverand MP, Clemmer RS, Redifer P, et al. A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann Rheum Dis. 2013;72:187–95.
53. Maricar N, Callaghan MJ, Felson DT, et al. Predictors of response to intra-articular steroid injections in knee osteoarthritis—a systematic review. Rheumatology (Oxford). 2013;52:1022–32.
54. Sawitzke AD, Shi H, Finco MF, et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum. 2008;58:3183–91.
55. Bennett AN, Crossley KM, Brukner PD, et al. Predictors of symptomatic response to glucosamine in knee osteoarthritis: an exploratory study. Br J Sports Med. 2007;41:415–9.
56. Bruyère O, Honore A, Rovati LC, et al. Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Scand J Rheumatol. 2002;31:13–6.
57. Bruyère O, Honore A, Ethgen O, et al. Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis Cartilage. 2003;11:1–5.
58. Englund M. The role of biomechanics in the initiation and progression of OA of the knee. Best Pract Res Clin Rheumatol. 2010;24:39–46.
59. Tanamas S, Hanna FS, Cicuttini FM, et al. Does knee malalignment increase the risk of development and progression of knee osteoarthritis? A systematic review. Arthritis Rheum. 2009;61:459–67.
60. Pfirrmann CW, Mengiardi B, Dora C, et al. Cam and pincer femoroacetabular impingement: characteristic MR arthrographic findings in 50 patients. Radiology. 2006;240:778–85.
61. Richmond SA, Fukuchi RK, Ezzat A, et al. Are joint injury, sport activity, physical activity, obesity, or occupational activities predictors for osteoarthritis? A systematic review. J Orthop Sports Phys Ther. 2013;43:515–B19.
62. Nicholls AS, Kiran A, Javaid MK, et al. Change in body mass index during middle age affects risk of total knee arthoplasty due to osteoarthritis: a 19-year prospective study of 1003 women. Knee. 2012;19:316–9.
63. Rodrigues PT, Ferreira AF, Pereira RM, et al. Effectiveness of medial-wedge insole treatment for valgus knee osteoarthritis. Arthritis Rheum. 2008;59:603–8.
64. Zaffagnini S, Marcheggiani Muccioli GM, Lopomo N, et al. Prospective long-term outcomes of the medial collagen meniscus implant versus partial medial meniscectomy: a minimum 10-year follow-up study. Am J Sports Med. 2011;39:977–85.
65. Huebner JL, Bay-Jensen AC, Huffman KM, et al. Alpha C-telopeptide of type I collagen is associated with subchondral bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis. Arthritis Rheumatol. 2014;66:2440–9.
66. Sharma AR, Jagga S, Lee SS, et al. Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis. Int J Mol Sci. 2013;14:19805–30.
67. Goldring SR, Goldring MB. Bone and cartilage in osteoarthritis: is what’s best for one good or bad for the other? Arthritis Res Ther. 2010;12:143.
68. Radin EL, Rose RM. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res. 1986;(213):34–40.
69. Herrero-Beaumont G, Roman-Blas JA. Osteoarthritis: Osteoporotic OA: a reasonable target for bone-acting agents. Nat Rev Rheumatol. 2013;9:448–50.
70. Carrino JA, Blum J, Parellada JA, et al. MRI of bone marrow edema-like signal in the pathogenesis of subchondral cysts. Osteoarthritis Cartilage. 2006;14:1081–5.
71. Castaneda S, Largo R, Calvo E, et al. Effects of estrogen deficiency and low bone mineral density on healthy knee cartilage in rabbits. J Orthop Res. 2010;28:812–8.
72. Calvo E, Castaneda S, Largo R, et al. Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits. Osteoarthritis Cartilage. 2007;15:69–77.
73. Bellido M, Lugo L, Roman-Blas JA, et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther. 2010;12:R152.
74. Bellido M, Lugo L, Roman-Blas JA, et al. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. Osteoarthritis Cartilage. 2011;19:1228–36.
75. Wang SX, Laverty S, Dumitriu M, et al. The effects of glucosamine hydrochloride on subchondral bone changes in an animal model of osteoarthritis. Arthritis Rheum. 2007;56:1537–48.
76. Roman-Blas JA, Castaneda S, Largo R, et al. An OA phenotype may obtain major benefit from bone-acting agents. Semin Arthritis Rheum. 2014;43:421–8.
77. Carbone LD, Nevitt MC, Wildy K, et al. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum. 2004;50:3516–25.
78. Karsdal MA, Bay-Jensen AC, Lories RJ, et al. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? Ann Rheum Dis. 2014;73:336–48.
79. Karsdal MA, Leeming DJ, Dam EB, et al. Should subchondral bone turnover be targeted when treating osteoarthritis? Osteoarthritis Cartilage. 2008;16:638–46.
80. Davis AJ, Smith TO, Hing CB, et al. Are bisphosphonates effective in the treatment of osteoarthritis pain? A meta-analysis and systematic review. PLoS One. 2013;8:e72714.
81. Laslett LL, Kingsbury SR, Hensor EM, et al. Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative. Ann Rheum Dis. 2014;73:824–30.
82. Goulston LM, Kiran A, Javaid MK, et al. Does obesity predict knee pain over fourteen years in women, independently of radiographic changes? Arthritis Care Res (Hoboken). 2011;63:1398–406.